News

AKBA

Akebia Therapeutics Raises $89 Million in Follow-on Offering for Kidney Disease Program

Edward Kim | Equities.com |

30 million people - 15% of US adults - suffer from chronic kidney disease.


IPO Report: Akebia Therapeutics (AKBA)

Francis Gaskins | Equities.com |

Akebia Therapeutics ($AKBA) is a biopharmaceutical company focused on the development of novel proprietary therapeutics headquartered in Cambridge, MA. Ten (always needs updating for the


11 IPOs Scheduled for the Week of March 17

Francis Gaskins | Equities.com |

The full IPO calendar is available at IPOpremium.  Scheduled IPOs are ranked by IPO size. (1) Based in San Jose, CA, A10 Networks (ATEN) scheduled a $175 million IPO on the NYSE with a market


China Stocks Rise As Inflation Numbers Please

Gene Linn | Equities.com |

China stocks continued on Friday to recover from steep losses in the first three days of the week, helped by lower-than-expected Chinese inflation figures. But the modest rally faces headwinds


Sponsored Financial Content

Market Movers